Journal Guide

Cardiology Journal (formelly Folia Cardiologica) is a scientific, peer-reviewed journal covering a broad spectrum of topics in cardiology. The journal has been published since 1994 and over the years it has become an internationally recognized journal of cardiological and medical community. This growing interest in Cardiology Journal is mostly due to constantly increasing quality of original papers submitted to the journal from all-over-the-world, excellent educational content with interesting review and how to do articles, and instructional case reports. Cardiology Journal is the journal for practicing cardiologists, researchers, and young trainees benefiting from broad spectrum of useful educational content. All these factors led the journal to receiving an international indexation in Medline, EMBASE, Index Copernicus (9.00), PBL GBL and Thomson Reuters database. The journal remains an official journal of several Working Groups of the Polish Cardiac Society.

Cardiology Research and Practice is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of cardiology.

Cardiology and Therapy is a fully open access, internationally peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). Emphasis is placed on the publication of high-quality practical and clinical research around new and existing therapies in all areas of cardiology, including interventional cardiology. Studies relating to diagnosis, health economics, outcomes research, patient care, management, and education are also encouraged. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, drug reviews, case reports, and short communications. Moving forward from traditional publishing, Cardiology and Therapy offers a range of additional features designed to increase visibility and readership. As such, each paper is accompanied by a bulleted slide summary giving a time-efficient overview of the content to a wider readership. All submissions have the option to include slide sets, video components, animations, and/or interactive case studies.Cardiology and Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the IJCME and GPP policies on acknowledgments/disclosures. Proposals for supplements are welcomed, and should be addressed to nicola.cartridge@springer.comFor authors: Upon acceptance of your article for publication, you will be required to pay the article open access fee of £175/€200/$260 per printed page. This will enable you to keep the copyright: you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open, access.

American Heart Association members are eligible for a 20% discount on subscription rates.Edited by some of the world's best-known authorities, Cardiology in Review provides readers with critical state-of-the-art reviews of topics that are relevant to current and future cardiovascular medicine and surgery practice. Each issue includes articles by leading international experts in the areas of cardiovascular epidemiology, pathophysiology, diagnostics, prevention, and therapeutics.Indexed in: MEDLINE/PUBMED, EMBASE, SCOPUS, Science Citation Index Expanded, Current Contents/Clinical MedicineWebsite: www.cardiologyinreview.com.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents. Each issue contains a series of timely in-depth reviews, original research articles and drug clinical trial studies written by leaders in the field covering a range of current topics in Cardiovascular & Hematological medicinal chemistry.

Cardiovascular Diabetology is ready to receive manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome: this includes genetic, experimental, clinical, pharmacological, epidemiological, molecular biology and laboratory research.

Cardiovascular Diabetology - Endocrinology Reports, an official companion journal to Cardiovascular Diabetology, is an open access journal publishing on clinical, translational and basic science aspects of endocrinology. The journal welcomes original research, reviews, commentaries and case reports on diabetes and all types of endocrine disorders including, but not limited to, metabolic syndrome, thyroid disorders, adrenal disorders, pituitary disorders, bone disorders, obesity, reproductive disorders and neuroendocrine disorders.  

The audience includes physicians, researchers, nurses, nutritionists, pharmacists, podiatrists, psychologists, epidemiologists, exercise physiologists and health care researchers. 

Designed to objectively cover the world of cardiovascular pharmacology and therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field. Homing in on the most exciting work being done on new therapeutic agents, heart failure, hypertension and acute myocardial infarction, among others, Cardiovascular Drugs and Therapy is an authoritative source of current and relevant news that is indispensable for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Current Contents and Index Medicus, the regular articles and frequent free supplementary issues equip you with an up-to-date source defined by the need for accurate information on an ever-changing field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of